Related Experiment Video
Updated: Jul 14, 2025
06:32
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
7.9K
Comparative Analysis of the Embryonal Brain Tumors Based on Their Molecular Features.
Valeriia Shcherbina1, Larysa Kovalevska1, Eugene Pedachenko2
1RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of National Academy of Sciences of Ukraine, 03022 Kyiv, Ukraine.
Discovery Medicine
|October 9, 2023
Summary
Pediatric embryonal brain tumors are aggressive childhood cancers. Understanding their molecular characteristics, like MYC/MYCN gene overexpression, is crucial for developing targeted diagnostics and personalized therapies.
Area of Science:
- Pediatric oncology
- Molecular biology
- Cancer genetics
Background:
- Pediatric brain tumors are the most common solid childhood malignancy and a leading cause of cancer-related death.
- Embryonal brain tumors represent a frequent and aggressive subtype with poor patient outcomes.
- Current diagnostic and therapeutic strategies require refinement through molecular understanding.
Purpose of the Study:
- To review and analyze the latest molecular characteristics of classified embryonal brain tumors.
- To highlight key molecular alterations driving tumor development and progression.
- To underscore the need for molecular insights for personalized treatment strategies.
Main Methods:
- Comprehensive literature review of recent studies on embryonal brain tumor molecular pathology.
- Analysis of genetic and epigenetic alterations, including gene expression patterns.
- Focus on molecular pathways implicated in cell proliferation, cell cycle regulation, and pluripotency.
Main Results:
- Overexpression of MYC and MYCN genes is a common feature, promoting cell proliferation and cell cycle dysregulation.
- Disturbances in the SWI2/SNF2 chromatin remodeling complex are observed in these malignancies.
- LIN28 and MYC are identified as key players in the induction of pluripotency.
Conclusions:
- Molecular mechanisms of central nervous system embryonal brain tumors are not fully elucidated.
- Identifying these mechanisms is essential for improving disease prognosis.
- Advances in molecular diagnostics are critical for developing personalized therapeutic approaches for pediatric brain tumors.
